[DOI] [PubMed] [Google Scholar] 2.Rogers LM, Boy E, Miller JW, Green R, Sabel JC, Allen LH
How They Work Support hepatic fat metabolism via MIC compounds Deliver nutrients at 100% IM absorption Support liver function and fat export Inositol sensitizes insulin signaling B12 restores metabolic energy foundation Best results as part of a broader protocol What Patients Report Improved energy levels often from week 1 Reduced afternoon fatigue Improved exercise capacity and recovery Reduced carbohydrate cravings (inositol) More consistent weight management progress Results vary with diet, exercise, and baseline How They Differ GLP-1: appetite suppression + glucose regulation Lipotropic: fat metabolism + liver function Not competitive different mechanisms Commonly combined for complementary support B12 addresses fatigue GLP-1 patients experience Inform your NP of all current medications Benefits of B12 & Lipotropic Injections
It benefits nutrient absorption, metabolism, brain function, and more
In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
chronic liver disease and hepatitis may present with elevated levels Renal impairment : Reduced clearance can contribute to accumulation, though this is rarely clinically significant Solid tumours : Certain malignancies, particularly hepatocellular carcinoma and metastatic disease, may elevate B12 levels [3] Evidence suggests that unexplained markedly elevated B12 levels without supplementation may sometimes be associated with underlying disease
As NAD+ supplementation research has expanded dramatically, the discovery that NNMT depletes NAD+ precursors specifically in metabolically dysfunctional fat tissue provides a targeted intervention point